Objective To examine the relationship between generation 1 (grandmaternal) cardiometabolic risk factors and generation 3 (grandchild's) birthweight and gestational age.
This work has spurred increased interest in the determinants of birthweight as well as how prenatal exposures may affect later-life health. It also leads to the hypothesis that exposures in 1 generation may have effects on multiple generations to come. If prenatal malnutrition or overnutrition in the first generation leads to changes in birthweight in second generation, the second generation's adult metabolic health would be altered, which would lead to effects on birth outcomes in the third generation. Alternately, nutrition in the first generation could have direct effects on the oocytes of the third generation, 3 change the microbiome, 4 or have epigenetic consequences, 5, 6 meaning that effects on the third generation could be as strong or stronger, and even affect subsequent generations.
Animal studies indicate the possibility of multigenerational inheritance related to nutrition and metabolism. [7] [8] [9] Very few human studies have examined multigenerational effects. In 1 study, generation 1 body mass index (BMI) was directly linked to generation 2 birthweight and BMI, but not third generation BMI, nor did metabolic syndrome in the first generation produce any changes in the birthweight of generations 2 or 3.
If the hypothesis of multigenerational transmission of metabolism is true, we would expect the metabolic or nutritional status of the grandmother to predict a baby's birthweight, 2 generations later. The grandmother's risk factors could also predict a shorter gestational age, 10, 11 which may also be an indicator of suboptimal intrauterine environment, 12 and prematurity may induce developmental programming. 13 We hypothesized that generation 1 (grandmother)'s risk factors would predict baby's birthweight and gestational age, and intrauterine undernutrition would produce low birthweight in generation 2, followed by increased risk for obesity/diabetes, leading to increased birthweight in generation 3.
Methods
The Bogalusa Heart Study (BHS) is a long-running study of childhood, adolescent, and now adult cardiovascular health, founded by Dr Gerald Berenson in 1973. 14 Participants were initially recruited from schools in Bogalusa, Louisiana, at ages 3-18 years. Over time, additional waves of data collection were performed, adding
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additional participants up to adulthood. Female participants have between 1 and 15 study visits, with a median of 2. In childhood, data collection occurred approximately every 2 years, and in adulthood, approximately every 5 years. Currently, participant ages are largely in the 40s through 60s, and followup for cardiovascular and early aging measures continues. The data linkages were approved by the Institutional Review Board of Tulane University under a waiver of informed consent. Parents and participants provided informed consent for original data collection and interviews.
Two linkages with reproductive outcomes have been performed. The first, performed in the early 90s, linked participants with their own birth certificates. The linkage was performed manually based on name and birthdate. A total of 6928 participants were linked to data on birthweight and gestational age. The second linkage was performed in 2012-2015. Female participants were linked to their children's birth certificates for Louisiana, Mississippi, and Texas births from 1982 to 2009, including a deterministic record linkage based on maternal social security number, and probabilistic linkage when social security number was unavailable. Furthermore, 1591 women also had been interviewed about their reproductive history during 2012-2016, including data on birthweight and gestational age of each pregnancy and birth.
Two Generation Linkage
First and last name of the mother had been recorded at some time point for 10 292 of the 12 138 study participants. A manual record review was conducted comparing maternal name with the names of the nearly 6000 female study participants. (An attempt to link to paternal participants proved impracticable.) A match was considered likely when the recorded maternal name was identical to the female participant's name, and the participant's age at the time of the child's birth was 16 years or higher. Situations in which the participant's name was similar to the reported maternal name (ie, common alternative spellings or possible misspellings, nicknames, or typos), or the name was identical but the participant would have been between the ages of 12 and 15 years at the time of the birth or the participant's birthdate was missing, were flagged as questionable matches. Using this method, 702 possible mother/child pairs were identified, including 114 questionable matches. Questionable matches were checked against reported addresses, when available, for further verification. Of the questionable matches, 24 were not verifiable (ie, participant was not in the 1994 census). For the remaining 90 questionable matches, 74 (82.2%) were confirmed using census data, and 2 of the incorrect matches were corrected using census data. Thus, of the 114 questionable matches, 100 were considered true matches based on the high verification rate (24 unchecked + 74 verified + 2 corrected). A random sample of 50 likely matches was also checked against BHS census data from 1994. Of these, 2 were not verifiable, and all of the remaining 48 verifiable matches were confirmed; thus, all 588 likely matches were considered true matches. In total, this process led to 688 mother/child pairs (688 children [generation 2] to 437 women [generation 1]).
Three-Generation Linkage
Of the 688 children (generation 2) matched during the mother/ child BHS match, 345 (50.2%) were female. Of these, 211 had been linked to at least 1 birth (433 individual live-births). After excluding multiple births, the 3-generation linkage included 424 3-generational triads: 177 generation 1 (grandmothers), 210 generation 2 (mothers), and 424 generation 3 (children). Data for both the first and second generation women was drawn from BHS visits, and data for the third generation was obtained from vital statistics (n = 383) and interviews (n = 41).
Exposure and Outcome Measures
Birthweight and gestational age (obstetric estimate) were taken from the vital statistics data, or, if this was not available, mother's report (mother's report of her infants' birth outcomes is generally valid [15] [16] [17] ). All participants were measured and weighed in duplicate in light clothing with shoes off; the average of the measures was used. Fasting blood samples were drawn by venipuncture and stored at −80°C until analysis. Cholesterol, triglycerides, and glucose were measured by enzymatic procedures (Olympus AU400e analyzer, Center Valley, Pennsylvania). Insulin was measured by radioimmunoassay Phadebas Insulin Kit (Pharmacia Diagnostics AB, Uppsala, Sweden). Plasma glucose was measured with enzymatic methods (Beckman Coulter, Indianapolis, Indiana). Measurements were made by laboratory technicians blinded to participants' risk factors. The BHS chemistry laboratory adheres to rigorous quality control procedures and has participated in the Centers for Disease Control and Prevention-National Heart, Lung, and Blood Institute Lipid Standardization Program since 1981. The intraclass correlation coefficient, a reliability measure of interindividual variability, for human blind duplicate samples ranged from 0.92 for glucose to 0.99 for total cholesterol. If multiple prepregnancy measures were available, the one closest in time to the pregnancy was used. Mean age at the BHS visit prior to pregnancy was 16.2 years for generation 1 and 11.1 years for generation 2.
Age was calculated from participant's date of birth. Race was recorded at the initial BHS visit. Smoking was based on reporting of current smoking at any visit. Parity was taken from number of reported pregnancies or birth certificate data; marital status and education (highest grade completed) were taken on self-report or as recorded on the birth certificate. Pregnancy weight gain was taken from vital statistics data or maternal selfreport, which is moderately if not perfectly associated with recorded data. 18 The reproductive history interview contained information on tobacco use, marital status at birth, parity, highest grade completed, and weight gain during pregnancy.
Statistical Analyses
To compare the included sample with the overall BHS sample, c 2 , t tests, and ANOVA were used for bivariate comparisons. Linear and logistic models were also used to determine whether differences remained after adjusting for age at first and last visit and race. The generation 1 women and the generation 2 women were compared with the overall sample in separate analyses.
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For the main analysis, first, 2-generation relationships with birth outcomes were examined. Generation 1's cardiometabolic factors at the visit prior to pregnancy were examined as predictors of generation 2's birth outcomes, and generation 2's cardiometabolic factors were examined as predictors of generation 3's birth outcomes. Birthweight and gestational age were examined as continuous outcomes to maximize study power. Multiple linear regression models were used for continuous outcomes and logistic models for dichotomous outcomes. Three models were used to examine the relationships: the first model was unadjusted, the second adjusted for maternal BMI, and the third also adjusted for known risk factors for birth outcomes (for generation 2: generation 3, age, smoking, race, marital status, education, parity, weight gain during pregnancy, and time between the BHS visit and pregnancy; for generation 1: generation 2, age, smoking, race, parity, and time between the BHS visit and pregnancy [less information was available for this analysis because generation 2's birth outcomes were taken from the first linkage, and no data was abstracted from the birth certificate beyond birthweight and gestational age]). Multiple imputation was used to account for missing data in covariates. 19 Models were generalized estimating equations with an exchangeable working correlation matrix to allow for correlation within family (generation 1).
Analysis 2 examined generation 1 characteristics as a predictor of generation 3's birthweight and gestational age. Generation 1 measurements at the visit prior in to the pregnancy with generation 2's were examined as predictors, with adjustment for maternal BMI (model 2), grandmaternal BMI if not the exposure, and for maternal age, race, smoking, parity, marital status, education, weight gain during pregnancy, and time between the BHS visit and the pregnancy (model 3). An additional analysis controlled for the corresponding mother's risk profile (eg, effect of grandmaternal glucose controlling for mother's glucose levels).
Analysis 3 examined whether discrepancies in the BMI of the generation 1 and 2 were associated with differences in the infant's birthweight and gestational age. The BMIs were categorized as (1) both generations 1 and 2 overweight/obese; (2) neither overweight nor obese; (3) generation 1 overweight/ obese/generation 2 not; and (4) generation 2 overweight/ obese/ generation 1 not. These 4 categories were examined as predictors of generation 3's birthweight/gestational age. A similar strategy was followed for other risk factors, with top quartile as the cut-off for "high."
Analysis 4 examined discrepancies in birthweight, looking at whether the generation 1's characteristics produced a pattern whereby one or the other of the generation 2 and generation 3 had lower birthweight, but the other was not. Because of the small numbers, "lower birthweight" was defined as <20th percentile for this study population.
Finally, we examined the hypothesis that intrauterine undernutrition would produce low birthweight in generation 2, followed by increased risk for obesity/diabetes, leading to increased birthweight in generation 3. We compared the group with generation 1 normal/underweight, generation 2 <20th percentile on birthweight, and generation 2 later BMI overweight/ obese, with all others. Analyses were performed using SAS software v 9.3 (SAS Institute, Cary, North Carolina) with 2-sided P values.
Results
The generation 1 and 2 women included in this analysis were 58% African American, 42% white, and the mean age at the BHS visit prior to pregnancy was 16.2 years for generation 1 and 11.1 years for generation 2 ( Table I) . Age of the generation 1 participants included in this analysis was older at earliest visit (14.4 vs 9.6 years) as well as most recent visit (34.5 vs. 18.8 years), compared with women in the overall BHS sample ( Table I) . Included participants were much more likely to be African American (58% of this sample, compared with 36% of the larger sample). Mean BMI and cholesterol were not different once race and age were accounted for, and blood pressure was slightly lower than women in the overall sample (systolic -1.31 mm Hg; P = .08). The included generation 1 participants were much more likely to be smokers (56% vs 36% ever smoked), though this, too, was somewhat explained by the age difference (P = .14 for differences in smoking, after adjustment for race and age). The included mothers had a younger age at earliest visit (mean 7.8 years) and latest visit (11.5 years) compared with the overall population of women. Mean BMI and cholesterol were not different once race and age were accounted for, and blood pressure was slightly lower (systolic -1.64 mm Hg; P < .01). Mean birthweight in the generation 1 was 3083 g, in the generation 2 was 3187 g, and in the generation 3 was 3037 g, and birthweights were correlated across generations (generation 1-generation 2, r = 0.39, P < .01; generation 2-generation 3, r = 0.24, P < .01).
Two-Generation Comparison
Generation 2 (mother) higher BMI was associated with higher birthweight (28 g per 1 unit of BMI, 95% CI 16, 40) and gestational age (0.08 weeks, 95% CI 0.02, 0.14) in the generation 3 (child), and generation 1 (grandmother) higher BMI was associated with higher birthweight (52 g, 95% CI 34, 70) in the generation 2 (mother) ( Table II) . Higher glucose and triglycerides in generation 2 were associated with increased birthweight and low-density lipoprotein (LDL) with higher gestational age in generation 3, but these were to some degree explained by confounding.
Three-Generation Comparison
Generation 1's glucose levels were associated with higher birthweight in generation 3 (adjusted beta = 111, 95% CI 33-189), and triglycerides (-21, −43 to 0) and LDL (-24, -48 to 0) were associated with lower birthweight (Table III) . Highdensity lipoprotein was weakly associated with higher gestational age (0.12, 0.00-0.24). Examination of discrepant risk factor patterns indicated associations of birth outcomes with both generation 1 and 2 ( Table IV) . The highest birthweight was seen in those with both generation 1 and generation 2 overweight/obese, although there was substantial overlap in the THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 181
CIs with the effects from a single generation being obese. Generation 1's glucose level was more strongly associated with birthweight than generation 2's, and the negative relationship between generation 1's LDL and birthweight was mostly in those whose generation 2's LDL was not high. Generation 2's triglycerides were mostly associated with higher gestational age if the generation 1 was not in the "high" category.
Generation 1 BMI was very strongly inversely associated with the pattern of generation 2 having a lower birthweight, but generation 3 not (OR per 1 unit, 0.81, 95% CI 0.69-0.96) ( Table V; available at www.jpeds.com), and higher generation 1 triglycerides were also associated with an increased likelihood of generation 3 having a lower birthweight, but generation 2 not (OR per 10 units, 1.10, 95% CI 1.00-1.20; data not shown).
Finally, comparing the group with generation 1 normal/ underweight, generation 2 <20th percentile on birthweight, generation 2 later BMI overweight/obese, to all others, birthweight in generation 3 was an average of 251 g (P = .13) higher, reduced after adjustment for confounding (adjusted beta 163 g, P = .35).
Discussion
The results of this study are consistent with a previous study in Malta that linked clinical databases for 182 mothers and daughters, who then gave birth to 233 infants, 20 in that maternal BMI was one of the strongest drivers of birthweight. Unlike this previous study, however, we did find some generation 1-generation 3 relationships with cardiometabolic factors. The Maltese study, however, was limited to what was recorded in a clinical database and, therefore, had much less detailed measures of the prepregnancy cardiometabolic risk factors.
Our results suggest the possibility of multigenerational developmental programming of birth outcomes, although mechanisms (whether biological or environmental) are undetermined. Also, although the Developmental Origins of Health and Disease research has linked low birthweight with both adult cardiovascular and metabolic health, 21 these effects may need to be distinguished for perinatal outcomes. It has long been known that maternal glucose is associated with higher birthweight, 22 but higher lipids have been associated with lower gestational age. 23 Animal work indicates the possibility of transgenerational or multigenerational influences on health, although the research is still in its early stages: maternal diet in generation 1 has been found to predict adiposity in mice through generation 3 and sometimes 4. 24, 25 Biological mechanisms that could account for effects on 3-generational effects could include epigenetic changes 24, 25 including changes in the oocytes or in tissues or altered gene expression. 26 It is also possible that nutritional or metabolic dysfunction in generation 1 could induce developmental programming of metabolism or hormone levels in generation 2 that was especially prominent under conditions of stress, such as being pregnant, thus amplifying or leading to additional programming of generation 3. 27 Our study considers only maternally mediated associations. Some studies indicate stronger paternal effects, or stronger effects working through the male offspring's line rather than the female; this was the case for the Overkälix study. 28 It is possible that our results would have been stronger, or different, if grandfathers or fathers could have been considered.
There were limitations to the study. Included participants were different from other BHS participants. Except for the race difference, these differences largely reflect the form of the study, which includes several cross-sectional studies for which there was little follow-up, and a core group that has been followed up multiple times; as well as the fact that allowing three generations generally requires that the earliest generation have entered the study at an older age. The sample for this analysis is limited to those who could be contacted and/or linked, which makes them different from the overall sample in the ways demonstrated in Table I ; there is no reason to believe, however, that biological mechanisms would operate differently in this group.
Other limitations are related to the available data. Prepregnancy cardiometabolic health is represented with a single measurement, closest in time to pregnancy. Some women do have multiple prepregnancy measures, but the number is too small for analysis (n = 26). Even using a single measure, the sample is small. A second limitation is the nonstandardized measurement timing, either at the same age or before pregnancy, which in some cases led to long gaps between the cardiovascular measurement and the pregnancy outcome. All of these factors limit our ability to detect anything beyond very large effects, and our ability to distinguish transgenerational from genetic and environmental effects.
Future studies should examine larger sample sizes; explore possible epigenetic and programming mechanisms of effect; include male generation 1 and 2 participants; and assess metabolic health in the third generation. A lthough vitamin E was identified as a fat-soluble nutrient in 1922, its precise role in human nutrition remained unclear for decades thereafter. Premature infants were noted to have low a-tocopherol concentrations, but the relationship of this observation to health outcomes was not established. In this seminal article, Oski and Barness observed that formula-fed premature infants aged 6-10 weeks developed an anemia that was associated with red cell hemolysis, as evidenced by reticulocytosis and a positive hydrogen peroxide hemolysis test. The authors concluded that this hemolysis was associated with vitamin E deficiency after studying 2 groups of premature infants. Therapy with adequate vitamin E led to increased hemoglobin levels and decreased reticulocyte counts. Vitamin E deficiency was attributed to low birth stores, dietary deficiency, and other factors affecting requirements (eg, intake of ascorbic acid, iron, unsaturated fatty acids). The mechanism of hemolysis in vitamin E deficiency, as well as the daily requirement for infants, were unclear.
Fast forward 50 years. Although rare in humans without mutations in the TTPA gene, fat malabsorption syndromes, or protein-energy malnutrition, vitamin E deficiency still occurs in premature infants. Supplemental intake of this antioxidant nutrient is associated with lower risk of retinopathy of prematurity, but not of bronchopulmonary dysplasia or intraventricular hemorrhage, and large doses may actually increase the risk of sepsis. Even in 2016, there is a lack of functional criteria of vitamin E status in infants. As a result, the recommended intake is based on adequate intake data calculated from the mean vitamin E intake of breast-fed infants. Moreover, the adequate intake is based only on the a-tocopherol form, not on other naturally occurring forms (b-, g-, and d-tocopherol and tocotrienols), which is a change from previous recommendations. The daily adequate intake of a-tocopherol is 4 mg (9.3 mmol) for infants aged 0-6 months and 5 mg (11.6 mmol) for infants aged 7-12 months.
This report not only identified a human requirement for vitamin E, but underscored the importance of functional markers in assessing a nutrient deficiency. Efforts are still needed to better understand vitamin E and its role in human nutrition, and especially to define biomarkers for assessing vitamin E status. 
